Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients
Clinical trial NCT02040064 · COMPLETED
Trial details
- NCT number
- NCT02040064
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.